1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CCL25 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA LST1 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA GEMIN2 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA NOS3 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA ABO CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA TULP3 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA MELTF CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA PRKCD CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA PKP3 CTRPv2 pan-cancer AAC 0.2 3e-05
mRNA LGALS8 CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV